{{Rsnum
|rsid=10492519
|Gene=FAM124A
|Chromosome=13
|position=51250192
|Orientation=plus
|GMAF=0.214
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=FAM124A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 29.2 | 46.2 | 24.6
| HCB | 96.4 | 3.6 | 0.0
| JPT | 96.5 | 3.5 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 93.0 | 7.0 | 0.0
| CHB | 96.4 | 3.6 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 51.5 | 43.6 | 5.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 41.1 | 44.6 | 14.3
| MKK | 96.2 | 3.8 | 0.0
| TSI | 35.3 | 53.9 | 10.8
| HapMapRevision=28
}}
[[rs10492519]] is one of seven SNPs found in a combined study of over 1,000 patients to be associated with increased risk for [[prostate cancer]]. The risk allele for this SNP is (G); and while the odds ratio was not specifically reported, the probability of false significance (not permuted though) was given as p=5.6 x 10e-6, using an additive model of risk.{{PMID|18073375}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}